Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
2.

Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.

De Bacquer D, Dallongeville J, Kotseva K, Cooney MT, Pajak A, Deckers JW, Mayer O, Vanuzzo D, Lehto S, Fras Z, Östor E, Ambrosio GB, De Backer G, Wood D, Keil U, Sans S, Graham I, Pyörälä K.

Int J Cardiol. 2013 Sep 30;168(2):910-4. doi: 10.1016/j.ijcard.2012.10.051. Epub 2012 Nov 14.

PMID:
23157810
3.

Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.

Omboni S, Malacco E, Mallion JM, Volpe M, Zanchetti A; Study Group.

J Hypertens. 2012 Jul;30(7):1468-77. doi: 10.1097/HJH.0b013e32835466ac.

PMID:
22573127
4.

Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.

Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, Reiner Z, Gaita D, Wood D, Kotseva K, Heidrich J; EUROASPIRE III Study Group.

J Hypertens. 2011 Aug;29(8):1641-8. doi: 10.1097/HJH.0b013e328348efa7.

PMID:
21720270
5.

Clinical profile and predictors of in-hospital outcome in patients with heart failure: the FADOI "CONFINE" Study.

Biagi P, Gussoni G, Iori I, Nardi R, Mathieu G, Mazzone A, Panuccio D, Scanelli G, Cicatello C, Rinollo C, Muriago M, Galasso D, Bonizzoni E, Vescovo G; CONFINE Study Group.

Int J Cardiol. 2011 Oct 6;152(1):88-94. doi: 10.1016/j.ijcard.2011.02.025. Epub 2011 Mar 11.

PMID:
21397348
6.

Eplerenone in patients with systolic heart failure and mild symptoms.

Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group.

N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14.

7.

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.

PMID:
20577089
8.

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, Agnelli G; AESOPUS Investigators.

Ann Intern Med. 2009 May 5;150(9):577-85.

PMID:
19414836
9.

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.

PMID:
19287307
10.

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.

PMID:
19286092
11.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
12.

Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study.

Lonati C, Morganti A, Comarella L, Mancia G, Zanchetti A; IPERDIA Study Group.

J Hypertens. 2008 Sep;26(9):1801-8. doi: 10.1097/HJH.0b013e328307a07f.

PMID:
18698215
13.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

14.

Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.

Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB; Warfarin Optimal Duration Italian Trial (WODIT) Investigators.

Thromb Res. 2005;116(4):301-6. Epub 2005 Jan 26.

PMID:
16038714
15.

Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.

Piccioli A, Lensing AW, Prins MH, Falanga A, Scannapieco GL, Ieran M, Cigolini M, Ambrosio GB, Monreal M, Girolami A, Prandoni P; SOMIT Investigators Group.

J Thromb Haemost. 2004 Jun;2(6):884-9.

16.

Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study.

Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB, Annicchiarico M, Bellis P, Bellotti P, De Maria R, Lavecchia R, Lucci D, Mathieu G, Opasich C, Porcu M, Tavazzi L, Cafiero M; TEMISTOCLE Investigators.

Am Heart J. 2003 Oct;146(4):E12.

PMID:
14564335
17.

Blood pressure is insufficiently controlled in European patients with established coronary heart disease.

Boersma E, Keil U, De Bacquer D, De Backer G, Pyörälä K, Poldermans D, Leprotti C, Pilotto L, de Swart E, Deckers JW, Heidrich J, Sans S, Kotseva K, Wood D, Ambrosio GB; EUROASPIRE I and II Study Groups.

J Hypertens. 2003 Oct;21(10):1831-40.

PMID:
14508188
18.

Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.

Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators.

J Thromb Haemost. 2003 Aug;1(8):1730-3.

19.

Heart failure: a skeletal muscle disorder?

Vescovo G, Ambrosio GB, Dalla Libera L.

Cardiologia. 1999 Dec;44 Suppl 1(Pt 1):295-9. Review. No abstract available.

PMID:
12497924
20.

Apoptosis and changes in contractile protein pattern in the skeletal muscle in heart failure.

Vescovo G, Ambrosio GB, Dalla Libera L.

Acta Physiol Scand. 2001 Mar;171(3):305-10. Review.

PMID:
11412142

Supplemental Content

Loading ...
Support Center